Combination of glyco-dendrimer targeting to DC-SIGN and Langerin with a TLR stimulus resulted in cross-presentation and enhanced gp100 specific CD8+ T cell activation, illustrating their great potential for intradermal anti-tumor vaccination strategies and shedding additional light on the requirements for glyco-vaccine formulation. Here, PMEL is linked to neoplasm.